Breast Cancer Aftercare Research Results
UKLC presents positive research at the 1st UK Lymphatic Science meeting
Attended by Yvette Jordan, UKLC Training Director, and Anna Parsons UKLC from The Oak Tree Clinic, Worthing. With Professor Mortimer hosting, UKLC presented data research with `significant` proven improvements for Lymphatic Pressure Therapy which is fantastic news for our future therapists and breast cancer clients. Results outway our expectations and as a new therapy, it is a huge leap forward.
UKLC collected research data from lymphatic pressure therapists Anna Parsons, Juliette Cross, and Yvette Jordan.
The three years of research for new breast cancer aftercare called Lymphatic Pressure Therapy was presented at the 1st UK Lymphatic Science Meeting 2019. UKLC worked alongside Dr. Elizabeth Haining, a Research Fellow at the Institute of Cardiovascular Sciences. Dr. Haining who had collated our data declared the results `significant` by the three Asterix on the whisker charts seen below.
This means that LPT has now been documented and scientifically proven as a therapy for the very early treatment of sub-clinical lymphoedema.
UKLC truly believes and can now prove that early treatment works for improved patient survivorship and a better recovery outcome and none of the patients have since developed lymphoedema.
Lymphoedema is a recognised complication of breast cancer treatment that can leave patients with impairments that significantly affect their daily lives and mental health. This assessment of a small group of patients indicates that LPT could be a viable treatment option for breast cancer patients with sub-clinical lymphoedema, a patient group that often feels neglected by the medical establishment until their disease worsens to the clinically recognised stage.
Yvette abstract_v2.docx
Microsoft Word document [16.3 KB]
26 patients participated in this research and after only four weeks they saw a significant reduction of their arm, particularly in the upper arm.
Three measurements were taken at the beginning and end. No patient had been diagnosed with lymphoedema but experienced early stages of sub-clinical lymphoedema with limited mobility, pain and discomfort issues.
Since the research was presented, follow up has shown they have not developed lymphoedema and the effects of their treatment have lasted.
There are 9 ranges of movement in Lymphatic Pressure Therapy and as with the limb reduction, the 3 Asterix indicates a scientifically proven result.
Read here what the patients had to say about LP therapy.
Lymphatic Pressure Therapy for breast cancer aftercare
SUMMARY
LPT significantly improves patient limb mobility and function
LPT significantly decreases affected limb measurement
LPT improves self-reported symptoms of sub-clinical Lymphoedema
LPT overall perceived by patients as beneficial
Print